Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.13B 919M 825M 762M 691M 1.29B 87.3B 1.31B 9.13B 3.63B 45.76B 3.45B 3.38B 145B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7B 1.05B 943M 870M 789M 1.48B 99.75B 1.49B 10.43B 4.14B 52.29B 3.94B 3.86B 166B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
66.81%
Yield 2024 *
-
Yield 2025 -
1 day-1.10%
1 week-1.10%
Current month-4.26%
1 month-2.60%
3 months+1.81%
6 months-7.61%
Current year+3.22%
1 week 4.48
Extreme 4.48
4.64
1 month 4.48
Extreme 4.48
4.77
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.25
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
23.27
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
21/09/20 Sell

Chairman

1,940,600 0.2495%
18/09/20 Sell

Director

3,670,000 0.4719%
18/09/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%-1.10%-22.98%-43.80% 929M
-0.08%-0.31%+54.85%+128.42% 1,140B
+0.76%+3.61%+41.21%+84.56% 641B
-0.10%-0.92%+25.60%+106.15% 507B
+0.63%+2.33%+49.21%+67.82% 383B
+0.87%-4.42%+61.07%+37.86% 347B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 266B
+0.41%+1.72%+53.35%+70.70% 240B
-0.44%+0.86%+31.03%+106.02% 197B
Average +0.14%+2.39%+32.04%+63.81% 401.47B
Weighted average by Cap. +0.26%+2.98%+42.02%+88.21%

Financials

2024 2025
Net sales 3.83B 574M 515M 475M 431M 806M 54.49B 816M 5.7B 2.26B 28.56B 2.15B 2.11B 90.57B 3.05B 457M 410M 379M 344M 642M 43.42B 650M 4.54B 1.8B 22.76B 1.72B 1.68B 72.18B
Net income 33.62M 5.04M 4.52M 4.18M 3.79M 7.08M 479M 7.17M 50.09M 19.89M 251M 18.92M 18.52M 796M -104M -15.65M -14.05M -12.97M -11.76M -21.98M -1.49B -22.25M -155M -61.75M -779M -58.75M -57.49M -2.47B
Net Debt 1.4B 210M 188M 174M 158M 295M 19.95B 299M 2.09B 829M 10.45B 788M 771M 33.15B 875M 131M 118M 109M 98.56M 184M 12.46B 186M 1.3B 518M 6.53B 492M 482M 20.71B
Projected Income Statement - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
27/10/26 CN¥4.490 -1.10% 4,671,900
26/10/26 CN¥4.540 -1.30% 4,834,100
23/10/26 CN¥4.600 -0.22% 7,687,600
22/10/26 CN¥4.610 +0.22% 5,256,800
21/10/26 CN¥4.600 +1.55% 5,978,203

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002424 Stock